HOPE HARTIG: Open Payments
NPI 1578168258 · MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 27 payments from 15 companies in 2025. Trend: 2023 $232 · 2024 $345 · 2025 $581
Food & beverage: $531Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 10 | $236 |
| Dexcom, Inc. | 3 | $65 |
| ABIOMED | 1 | $40 |
| Tandem Diabetes Care, Inc. | 1 | $31 |
| Medtronic, Inc. | 1 | $24 |
| BETA BIONICS, INC. | 2 | $22 |
| Sequel Med Tech, LLC | 1 | $21 |
| CeQur Corporation | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Ascensia Diabetes Care Us Inc. | 1 | $20 |
Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, FREESTYLE INSULINX, t:slim X2 Insulin Pump with Control-IQ, INCEPTIV, iLet Bionic Pancreas, TWIIST, CeQur Simplicity.
Industry payments across MN — which companies pay providers there.
